Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India-Reference-Cited by-同舟云学术

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India

Published:2022-09-02 Issue:6 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Kalappanavar Nijalingappa K.¹,Ghosh Apurba²,Sharma Monika³,Ravichandran Latha⁴,Choraria Nirmal⁵,P Saravanan⁶,Pandey Madhukar⁷,N Pradeep⁸,Shah Prachee⁹,Nair Sneha¹⁰,Shaikh Ashfaque¹⁰,van de Witte Serge¹¹

Affiliation:

1. Department of Pediatrics, S.S Institute of Medical Sciences and Research Center, Davangere, India

2. Department of Pediatrics, Institute of Child Health, Kolkata, India

3. Department of Pediatric Medicine, Christian Medical College & Hospital, Ludhiana, India

4. Department of Pediatric Medicine, Sri Ramachandra Hospital, Chennai, India

5. Department of Pediatrics, Nirmal Hospital Pvt. Ltd, Surat, India

6. Department of Paediatrics, Sapthagiri Institute of Medical Sciences & Research Centre, Bangalore, India

7. Department of Pediatrics, Oriana Hospital, Varanasi, India

8. Department of Immunology, Cheluvamba Hospital, Opposite Mysore Medical College and Research Institute, Mysore, India

9. Department of Pediatrics, Panchshil Hospital, Ahmedabad, India

10. Established Pharmaceuticals Division, Abbott India Ltd, Mumbai, India

11. Established Pharmaceuticals Division, Abbott Healthcare Products B.V., Weesp, The Netherlands

Funder

Abbott India Ltd

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2104527

Reference30 articles.

1. World Health Organization (WHO). Influenza (seasonal)-ask the experts: Q&A. WHO; 2018 Nov 6 Archived from the original on 2019 Oct 25 [accessed 2020 Jun 16]. https://www.who.int/news-room/fact-sheets/detail/influenza-seasonal.

2. Content source: Centers for Disease Control and Prevention, National Center for ×Immunization and Respiratory Diseases. Types of influenza viruses. U.S. Department of Health & Human Services; 2019 Nov 18 [accessed 2020 Jun 16]. https://www.cdc.gov/flu/about/viruses/types.htm.

3. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

4. Immunization Action Coalition (IAC). Influenza: questions and answers information about the disease and vaccines. Saint Paul, Minnesota: IAC; 2020 [accessed 2020 Feb 6]; https://www.immunize.org/catg.d/p4208.pdf.

5. World Health Organization (WHO). Biologicals: influenza. WHO; 2019 Jun 19 [accessed 2020 Jun 12]. http://www.who.int/biologicals/vaccines/influenza/en/.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influvac Tetra: clinical experience on safety, efficacy, and immunogenicity;Expert Review of Vaccines;2023-12-15

2. Side effects of vaccines;Side Effects of Drugs Annual;2023